Current Pharmacogenomics and Personalized Medicine
Title:Editorial: CPPM 2013 Onward: Building a Socio-Technical GPS for Global Personalized Medicine – A Welcome to Editors-In-Chief Adrian LLerena (Spain) and Ross A. McKinnon (Australia)
Volume: 11 Issue: 2
Author(s): Vural Ozdemir, Adrian LLerena, Ross A. McKinnon, Sanjeeva Srivastava, Edward S. Dove, Lynnette R. Ferguson, Mario Masellis, Bipin Nair, David Gurwitz and Louise Warnich
Affiliation:
Keywords: Developing world pharmacogenomics, genomics and global personalized medicine; genomics without borders; global governance of technology and uncertainty; public health pharmacogenomics; responsible innovation; science and technology studies (STS); STS and organizations.
Export Options
About this article
Cite this article as:
Ozdemir Vural, LLerena Adrian, McKinnon Ross A., Srivastava Sanjeeva, Dove Edward S., Ferguson Lynnette R., Masellis Mario, Nair Bipin, Gurwitz David and Warnich Louise, Editorial: CPPM 2013 Onward: Building a Socio-Technical GPS for Global Personalized Medicine – A Welcome to Editors-In-Chief Adrian LLerena (Spain) and Ross A. McKinnon (Australia), Current Pharmacogenomics and Personalized Medicine 2013; 11 (2) . https://dx.doi.org/10.2174/1875692111311020001
DOI https://dx.doi.org/10.2174/1875692111311020001 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Detection of Tumor Markers with ProteinChip® Technology
Current Pharmaceutical Biotechnology Applications and Limitations of Genetically Modified Mouse Models in Drug Discovery and Development
Current Drug Metabolism Rational Drug Design: The Search for Ras Protein Hydrolysis Intermediate Conformation Inhibitors with Both Affinity and Specificity
Current Pharmaceutical Design Redox-active and Redox-silent Compounds: Synergistic Therapeutics in Cancer
Current Medicinal Chemistry Progresses in TCM Metal-Based Antitumour Agents
Anti-Cancer Agents in Medicinal Chemistry Targeting Never-In-Mitosis-A Related Kinase 5 in Cancer: A Review
Current Medicinal Chemistry Hepatocellular Carcinoma: Important Biomarkers and their Significance in Molecular Diagnostics and Therapy
Current Medicinal Chemistry TNF-α Induction by Nickel Compounds is Specific Through ERKs/AP-1- Dependent Pathway in Human Bronchial Epithelial Cells
Current Cancer Drug Targets Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling
Current Cancer Drug Targets A High-throughput Quantitative Expression Analysis of Cancer-related Genes in Human HepG2 Cells in Response to Limonene, a Potential Anticancer Agent
Current Cancer Drug Targets Molecular Targets for Nutritional Preemption of Cancer
Current Cancer Drug Targets Bioinformatics Approaches for Anti-cancer Drug Discovery
Current Drug Targets Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets Targeted Drug Delivery Via Human Epidermal Growth Factor Receptor for Sustained Release of Allyl Isothiocyanate
Current Topics in Medicinal Chemistry Melanocortins and their Receptors and Antagonists
Current Drug Targets n-3 Polyunsaturated Fatty Acids as Signal Transduction Modulators and Therapeutical Agents in Cancer
Current Signal Transduction Therapy CD147 Promotes Melanoma Progression Through Hypoxia-Induced MMP2 Activation
Current Molecular Medicine A Selective, Expeditious and Sustainable Entry en Route to Benzopyrazines and bis-Benzopyrazines
Combinatorial Chemistry & High Throughput Screening The Multifaceted Activities of Mammalian Defensins
Current Pharmaceutical Design Characteristic Alterations of Nuclear Structure and Chromatin Organisation of Cancer Cells Addressed by Proteome Analysis**
Current Proteomics